EP
ZLAB icon

Eversept Partners’s Zai Lab ZLAB Stock Holding History

Eversept Partners’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-102,930
Closed -$2.7M – 75
2024
Q4 		$2.7M Sell
102,930
-32,289
-24% -$896K 0.24% 53
2024
Q3 		$3.26M Buy
+135,219
New +$2.56M 0.22% 50
2023
Q3 		– Sell
-55,176
Closed -$1.53M – 79
2023
Q2 		$1.53M Sell
55,176
-116,823
-68% -$3.82M 0.13% 61
2023
Q1 		$5.72M Buy
+171,999
New +$6.6M 0.4% 41

Other funds holding ZLAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Eversept Partners's ZLAB Position: Q1 2025 in Review

Eversept Partners sold out of Zai Lab (ZLAB) in Q1 2025, closing a stake of 102,930 shares — an estimated $2.7M sold.

Eversept Partners first reported a position in ZLAB in Q1 2023 and held it in 4 quarters. The position peaked at $5.72M in Q1 2023. 160 funds tracked by Wall St. Rank hold ZLAB as of Q1 2025.

  • Eversept Partners reported no remaining Zai Lab position as of Q1 2025 after selling out during the quarter.
  • Eversept Partners sold 102,930 Zai Lab shares in Q1 2025, an estimated $2.7M.
  • Eversept Partners first reported a position in Zai Lab in Q1 2023 and held it in 4 quarters.
  • Eversept Partners's Zai Lab position peaked at $5.72M in Q1 2023.
  • 160 funds tracked by Wall St. Rank held Zai Lab as of Q1 2025.

Based on Eversept Partners's 13F filing for Q1 2025, filed 15 May 2025.